Helicobacter Pylori (Helicobacter pylori) is a bacterium found in the lining of the stomach and can cause chronic inflammation of the gastric mucosa. It is present in approximately 60% of the population in Israel. In some individuals, it may lead to the development of gastric or duodenal ulcers (ulcus), and even increase the long-term risk of gastric cancer. Infection with Helicobacter Pylori usually occurs through direct contact with the saliva, oral secretions, or feces of an infected person. Therefore, it can be transmitted through sharing eating utensils, kissing, or consuming contaminated food and water.
Infection most often occurs during childhood, especially in areas with lower hygiene standards or when living in crowded conditions. Sometimes the bacterium remains in the body without symptoms for years.
Diagnosis is performed using a breath test, stool test, or biopsy during gastroscopy. Treatment involves a combination of antibiotics to eradicate the bacterium and medications to reduce stomach acidity, aiming for complete healing of the mucosa and preventing ulcer recurrence. Some studies suggest combining probiotics alongside drug therapy.